Axel Bolte - Jun 24, 2021 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
Chief Executive Officer, Director
Signature
/s/ Axel Bolte
Stock symbol
INZY
Transactions as of
Jun 24, 2021
Transactions value $
$65,446
Form type
4
Date filed
6/25/2021, 07:58 AM
Previous filing
May 20, 2021
Next filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INZY Common Stock Options Exercise $65.5K +66.8K +35% $0.98* 258K Jun 24, 2021 Direct
transaction INZY Common Stock Sale -$7 -66.8K -25.93% $0.00* 191K Jun 24, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INZY Stock Option (right to buy) Options Exercise $0 -66.8K -39.93% $0.00 100K Jun 24, 2021 Common Stock 66.8K $0.98 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a transfer by Reporting Person to HBM Partners AG in satisfaction of Reporting Person's obligation pursuant to a prior agreement with Reporting Person's former employer.
F2 These options are fully vested.